T

Thinksono

www.thinksono.com link_icon

Company Research Report: ThinkSono



1. Company Overview



  • Name: ThinkSono

  • Mission: The mission of ThinkSono is to enable any healthcare professional to perform Deep Vein Thrombosis (DVT) ultrasound scans at the point of care using AI.

  • Founded: 2016

  • Founders: Fouad Al Noor and Sven Mischkewitz

  • Key People:

  • Fouad Al Noor: Chief Executive Officer, Co-Founder

  • Sven Mischkewitz: Chief Technology Officer, Co-Founder

  • Michael Blaivas, MD: Chief Medical Officer

  • Dr. Bernhard Kainz: Scientific Lead & Machine Learning Consultant

  • Dr. Mattias Heinrich: Scientific Lead & Machine Learning Consultant

  • Beverley Scott: Chief Safety Officer

  • Jonas Oppenheimer, MD: Lead Medical Analyst

  • Giancarlo Speranza, MBA, MD: Clinical Consultant, Vascular Surgery

  • Headquarters: No information is available.

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: ThinkSono is known for its AI-powered solutions for the detection of Deep Vein Thrombosis (DVT) using ultrasound technology.


2. Products



ThinkSono Guidance



  • Description: ThinkSono Guidance is an AI-powered platform designed to assist healthcare professionals in performing DVT ultrasound scans. It guides the user through a compression ultrasound examination process.

  • Key Features:

  • AI-guided ultrasound scans for quick and accurate data collection.

  • CE Class IIb regulatory approval for use in the EU/UK.

  • Reduces the waiting time for DVT diagnostic results from hours to minutes.

  • Allows non-ultrasound trained professionals to perform DVT exams.


Additional Products


  • Ultrasound AI – Training: Aimed at training healthcare professionals on AI-supported ultrasound technology.


3. Recent Developments



  • New Products and Features:

  • Released real-time DVT AI training solutions for Butterfly Network’s handheld ultrasound devices.

  • Introduced a new AI-guided ultrasound system with Clarius for rapid DVT assessment.


  • Partnerships:

  • Strategic partnership with the Point-of-Care Ultrasound Certification Academy.

  • Collaborations with NYU Langone Health and Temple Health for conducting clinical studies in the U.S.

  • Partnership with Butterfly Garden platform for deploying AI technology.


  • Regulatory and Financial Milestones:

  • Secured £2.1Mn ($2.7Mn) in funding and achieved EU regulatory approvals.

  • Ongoing study partnerships with several NHS trusts in the UK to validate the effectiveness of ThinkSono's AI solutions.


  • Recognition and Awards:

  • Selected as one of the top 96 AI companies by CB Insights.

  • Winner of the German Innovation Prize, Falling Walls Berlin Science Startups, and Wales Precision Medicine Challenge.


4. Research and Studies



  • Ongoing Studies: ThinkSono is involved in multiple research initiatives, including a feasibility study on remote DVT diagnosis and collaborations on AI-guided compression sonography for remote triaging.


This report provides a structured and comprehensive overview of ThinkSono, emphasizing the firm’s dedication to improving healthcare diagnostics through cutting-edge AI technology. Please note that certain details such as the company's headquarters location, employee count, and revenue remain unavailable.